Zota Health Care Ltd.

₹1,303.2

-14.1 (-1.1%)

ZOTA Share Price

Pharmaceuticals & Biotechnology

As on April 28, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 4,509 Cr

P/E Ratio-66.17

Dividend Yield0.01 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	1,302.16	Bullish
10-DMA	1,307.84	Bearish
20-DMA	1,240.59	Bullish
50-DMA	1,228.72	Bullish
100-DMA	1,344.02	Bearish
200-DMA	1,371.96	Bearish

Historical Performance

1 Year

54.1%

3 Years

351.4%

5 Years

743.5%

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	2,927	1,804	1,399	1,312	1,068
Total Expenditure	2,987	1,729	1,332	1,167	1,062
Other Income	24	12	26	20	13
Operating Profit	-37	87	93	164	19
Interest	108	48	26	3	1
Depreciation	432	201	120	37	32
Profit Before Tax	-576	-162	-47	124	-4
Consolidated Net Profit	-564	-143	-58	89	-2
Adjusted EPS	-20	-6	-2	4	---

Compounded Sales Growth

10 Years:27.9

5 Years:25.2

3 Years:17.4

TTM:10.2

Compounded Profit Growth

10 Years:28.6

5 Years:48.1

3 Years:17

TTM:31.5

Stock Price CAGR

10 Years:N/A

5 Years:53.3

3 Years:65.2

TTM:49.5

Return on Equity

10 Years:N/A

5 Years:-0.1

3 Years:-2.3

last year:-19.7

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	286	258	252	252	246
Total Reserves	1,950	641	552	645	417
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	1,027	603	361	134	10
Other Current Liabilities	415	191	103	126	17
Short Term Borrowings	6	147	---	---	---
Total Liabilities	4,305	2,239	1,570	1,389	855
Capital Work in Progress	56	48	31	---	---
Long Term Loans & Advances	1	1	1	1	3
Currents Investments	---	---	---	---	---
Short Term Loans and Advances	311	218	107	84	22
Total Current Assets	1,842	1,116	842	769	612
Total Assets	4,305	2,239	1,570	1,389	855
Adjusted Book Value	78	35	32	36	27

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a low PE of -66.17, which may indicate undervaluation or subdued growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 65.8%, indicating sustained price appreciation.
The stock carries a high beta of 1.3, implying higher volatility and elevated risk.
In the last financial year, the company reported a negative or negligible EBITDA of ₹-37 million, indicating weak operating profitability.
In the previous financial year, the company generated revenue of ₹2927 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1495095.5

No. of Shares: 1147 (Approx)

Performance:49.5%

P/L: ₹495095.5

NIFTY Performance: -1.4%

1 day Top Gainers